JP2011506393A5 - - Google Patents

Download PDF

Info

Publication number
JP2011506393A5
JP2011506393A5 JP2010537432A JP2010537432A JP2011506393A5 JP 2011506393 A5 JP2011506393 A5 JP 2011506393A5 JP 2010537432 A JP2010537432 A JP 2010537432A JP 2010537432 A JP2010537432 A JP 2010537432A JP 2011506393 A5 JP2011506393 A5 JP 2011506393A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
hydrogen
group
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010537432A
Other languages
English (en)
Japanese (ja)
Other versions
JP5577256B2 (ja
JP2011506393A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/067189 external-priority patent/WO2009077401A1/en
Publication of JP2011506393A publication Critical patent/JP2011506393A/ja
Publication of JP2011506393A5 publication Critical patent/JP2011506393A5/ja
Application granted granted Critical
Publication of JP5577256B2 publication Critical patent/JP5577256B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010537432A 2007-12-14 2008-12-10 抗腫瘍化合物 Expired - Fee Related JP5577256B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07380361.1 2007-12-14
EP07380361 2007-12-14
PCT/EP2008/067189 WO2009077401A1 (en) 2007-12-14 2008-12-10 Antitumoral compounds

Publications (3)

Publication Number Publication Date
JP2011506393A JP2011506393A (ja) 2011-03-03
JP2011506393A5 true JP2011506393A5 (enExample) 2013-01-17
JP5577256B2 JP5577256B2 (ja) 2014-08-20

Family

ID=40290734

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010537432A Expired - Fee Related JP5577256B2 (ja) 2007-12-14 2008-12-10 抗腫瘍化合物

Country Status (8)

Country Link
US (1) US8748388B2 (enExample)
EP (1) EP2231695B1 (enExample)
JP (1) JP5577256B2 (enExample)
CN (1) CN101932592B (enExample)
AU (1) AU2008337605B2 (enExample)
CA (1) CA2708080C (enExample)
ES (1) ES2406107T3 (enExample)
WO (1) WO2009077401A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
WO2013063296A1 (en) * 2011-10-25 2013-05-02 The Scripps Research Institute Synthesis of libraries of peptide tertiary amides
TWI807411B (zh) 2017-04-27 2023-07-01 西班牙商瑪製藥股份有限公司 抗腫瘤化合物
CN111777668B (zh) * 2020-07-28 2022-02-25 安徽工程大学 一种基于海洋环肽Samoamide A的改造多肽、合成方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681813A (en) 1994-04-06 1997-10-28 Pharma Mar, S.A. Thiodepsipeptide isolated from a marine actinomycete
CA2430782A1 (en) * 2000-12-21 2002-06-27 The Scripps Research Institute Analogues of thiocoraline and be-22179

Similar Documents

Publication Publication Date Title
JOP20210001A1 (ar) مشتقات 3-(5- هيدروكسي -1- أوكسو أيزو إندولين -2- يل) بيبريدين -2، 6- دايون واستخدامها لمعالجة أمراض مرتبطة ببروتين ذات أصبع الزنك من عائلة (ikaros 2 (ikzf2
JP2016516043A5 (enExample)
JP2011219498A5 (enExample)
JP2016506962A5 (enExample)
JP2011513305A5 (enExample)
JP2015522650A5 (enExample)
JP2016506960A5 (enExample)
WO2006069155A3 (en) Inhibitors of protein arginine methyl transferases
JP2014525420A5 (enExample)
JP2015531773A5 (enExample)
JP2014503574A5 (enExample)
JP2008535903A5 (enExample)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2016513696A5 (enExample)
JP2009539943A5 (enExample)
WO2012147107A3 (en) Novel & improved processes for preparing indoline derivatives and its pharmaceutical composition
JP2013514980A5 (enExample)
JP2018531987A5 (enExample)
JP2014508804A5 (enExample)
JP2014506907A5 (enExample)
WO2008147557A3 (en) Heteroaryl substituted thiazoles and their use as antiviral agents
JP2013542261A5 (enExample)
JP2017501237A5 (enExample)
MX336505B (es) Metodos y composiciones para reducir la grasa y los adipocitos del cuerpo.
JP2015535847A5 (enExample)